Can ischemia-modified albumin help in differentiating myocardial perfusion scintigraphy results?

Ede H., Yaylak B., Akkaya S., Karacavus S., GÖÇMEN A. Y., Erbay A. R.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.44, no.5, pp.380-388, 2016 (ESCI) identifier identifier identifier


Objective: Myocardial perfusion scintigraphy (MPS) is a diagnostic tool commonly used to detect significant coronary lesion. However equivocal, false negative or positive results can be yielded. Controversial findings regarding the role of ischemia-modified albumin (IMA) in MPS evaluation persist. The aim of the present study was to examine the role of serum IMA in the assessment of MPS results.